|
 |
| ©2004-2008, Quantum Laboratories,
Inc.. All rights reserved.
|
|
|
|
|
|
|
|
|
Major
depressive disorders with psychotic features
•
Protocol C-1073-07 A Randomized, Double Blind , Placebo-Controlled
Study of Safety and efficacy of C-1073 (Mifepristone) in
the acute treatment of Major Depressive Disorder with Psychotic
Features.
For
more information please call (561) 687-2111
|
|
|
|
|
|
|
Our facility identifies and recruits appropriate patients and
monitors them during the study. If you qualify and consent to
participate, there will be no charge for your study medication
and office visits. Additionally, you are responsible for attendence
to regular scheduled appointments.
|
|
|
|
|
Fact:
During any one-year period, up to 50 million Americans suffer
from clearly diagnosable mental disorder involving a degree
of incapacity that interferes with employment, attendence at
school or daily life.
|
|
|
|
